{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:39:14Z","timestamp":1793299154566,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.dld.2021.11.012","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T15:51:33Z","timestamp":1639151493000},"page":"890-895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study"],"prefix":"10.1016","volume":"54","author":[{"given":"Gianluca","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cazzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rinzivillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Pilozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Lahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2789-4289","authenticated-orcid":false,"given":"Francesco","family":"Panzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.11.012_bib0001","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4251\/wjgo.v12.i8.850","article-title":"Gastric neuroendocrine tumor: a practical literature review","volume":"12","author":"Roberto","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.dld.2021.11.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/287825","article-title":"Current concepts on gastric carcinoid tumors","volume":"2012","author":"Nikou","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.dld.2021.11.012_bib0003","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.dld.2021.11.012_bib0004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.dld.2020.08.031","article-title":"Update on gastroenteropancreatic neuroendocrine tumors","volume":"53","author":"Andreasi","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2021.11.012_bib0005","first-page":"29","article-title":"Gastroenteropancreatic neuroendocrine tumors: diagnosis and treatment","volume":"26","author":"Marc D\u00edez","year":"2013","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.dld.2021.11.012_bib0006","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-F","article-title":"Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study","volume":"104","author":"Rindi","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.11.012_bib0007","series-title":"Digestive system tumours. who classification of tumours","article-title":"Neuroendocrine neoplasms","year":"2019"},{"key":"10.1016\/j.dld.2021.11.012_bib0008","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/apt.12698","article-title":"Review article: the investigation and management of gastric neuroendocrine tumours","volume":"39","author":"Basuroy","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.11.012_bib0009","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3109\/00365521.2014.968859","article-title":"Updated features associated with type 1 gastric carcinoids patients: a single-center study","volume":"49","author":"Lahner","year":"2014","journal-title":"Scan J Gastroenterol"},{"key":"10.1016\/j.dld.2021.11.012_bib0010","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00268-011-1137-0","article-title":"Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor","volume":"35","author":"Zhang","year":"2011","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.dld.2021.11.012_bib0011","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000489902","article-title":"Prognostic evaluations tailored to specific gastric neuroendocrine neoplasms: analysis of 200 cases with extended follow-up","volume":"107","author":"Vanoli","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.dld.2021.11.012_bib0012","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/MEG.0000000000001697","article-title":"Narrow band imaging characteristics of gastric polypoid lesions: a single-center prospective pilot study","volume":"32","author":"Esposito","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.11.012_bib0013","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.dld.2019.04.016","article-title":"Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: a multicentre retrospective study","volume":"51","author":"Panzuto","year":"2019","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2021.11.012_bib0014","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/apt.12177","article-title":"Systematic review: gastric cancer incidence in pernicious anaemia","volume":"37","author":"Vannella","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.11.012_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6679397","article-title":"Comparison of endoscopic techniques in the management of type i gastric neuroendocrine neoplasia: a systematic review","volume":"2021","author":"Panzuto","year":"2021","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.dld.2021.11.012_bib0016","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3109\/00365521.2015.1010570","article-title":"Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up","volume":"50","author":"Lahner","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2021.11.012_bib0017","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000329043","article-title":"Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate","volume":"95","author":"Merola","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.dld.2021.11.012_bib0018","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.dld.2020.10.038","article-title":"Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region","volume":"53","author":"Esposito","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2021.11.012_bib0031","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2021.11.012_bib0019","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2021.11.012_bib0020","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/jcm8060910","article-title":"Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center","volume":"8","author":"Magi","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.dld.2021.11.012_bib0021","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000199786","article-title":"Histopathological classification of nonantral gastric endocrine growths in man","volume":"41","author":"Solcia","year":"1998","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2021.11.012_bib0022","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.suronc.2020.08.015","article-title":"Gastro-entero-pancreatic neuroendocrine neoplasia: the rules for non-operative management","volume":"35","author":"Panzuto","year":"2020","journal-title":"Surg Oncol"},{"key":"10.1016\/j.dld.2021.11.012_bib0023","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MEG.0000000000001900","article-title":"Rate of lymph node metastasis in patients with T1 gastric carcinoid tumors","volume":"32","author":"Ramai","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.11.012_bib0024","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.3748\/wjg.v19.i46.8687","article-title":"Metastatic type 1 gastric carcinoid: a real threat or just a myth?","volume":"19","author":"Grozinsky-Glasberg","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2021.11.012_bib0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000510962","article-title":"Selective Resection of Type 1 Gastric Neuroendocrine Neoplasms and the Risk of Progression in an Endoscopic Surveillance Programme","volume":"38","author":"Chin","year":"2021","journal-title":"Dig Surg"},{"key":"10.1016\/j.dld.2021.11.012_bib0026","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3748\/wjg.v20.i1.118","article-title":"Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors","volume":"20","author":"Li","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2021.11.012_bib0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000334038","article-title":"Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors","volume":"96","author":"Panzuto","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.dld.2021.11.012_bib0028","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.dld.2021.11.012_bib0029","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-12-0836","article-title":"Long-term follow-up of a large series of patients with type1 gastric carcinoid tumors: data from a multicenter study","volume":"168","author":"Thomas","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dld.2021.11.012_bib0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12020-015-0584-z","article-title":"Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study","volume":"51","author":"Campana","year":"2016","journal-title":"Endocrine"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821008525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821008525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:18:57Z","timestamp":1761625137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821008525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1590865821008525"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.11.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}